The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, ...

INBRAIN partners with Microsoft to use agentic AI and Azure cloud tech for next-gen brain-computer therapeutics.

Cognixion’s Vision Pro study shows how Apple’s accessibility framework is shaping the future of healthcare and communication ...

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

OpenAI is working on something big, developing its own brain-computer interface. But what does this actually mean?

Synchron announced today that it raised $200 million in a Series D financing round to support the commercialization of its ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...